Ceribell
NASDAQ: CBLLSunnyvale, US · Delaware corporation · 4 known investors
Find your way into Ceribell
202 people in our graph share verified history with the Ceribell team — schools, employers, funds. One of them is your warm intro.
Patrickunlockedknows Josef Parvizi · together at University of Oslo (overlapped)
×5knows the team · via University of Iowa
×3knows the team · via Harvard Medical School
knows the team · via Ceribell
×2knows the team · via University of Oslo
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.
Founders & leadership
JP

Josef ParviziinCo-FounderJosef Parvizi is a neurologist with clinical experience treating seizure disorders who has worked on the development of medical devices and procedures for neurodiagnostic care.
X(

Xingjuan (Jane) ChaoinPresident, CEO, Co-Founder & Director
SB

Scott BlumberginChief Financial Officer
JT
Joseph TaylorNamed on SEC filing
RW
Raymond WooNamed on SEC filing
DS
David StoffelNamed on SEC filing
WB
William BurkeNamed on SEC filing
RR
Rebecca RobertsonNamed on SEC filing
DR
Dan RogyNamed on SEC filing
Board
LI
Lucian IancoviciBoard director
JT
Julie Tammenoms BakkerBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$102.5M disclosed across 1 round · 2021
▶$102.5MraisedSep 2022 · 17 investors · Other Health CareRule 506(b)
▶$102.5MraisedSep 2022 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph TaylorDirector
- Scott BlumbergExecutive Officer
- Lucian IancoviciDirector
- Raymond WooExecutive Officer
- Josef ParviziDirector
- David StoffelExecutive Officer
- Xingjuan ChaoExecutive Officer, Director
- William BurkeDirector
- Julie Tammenoms BakkerDirector
- Rebecca RobertsonDirector
- Dan RogyExecutive Officer
- Offering amount
- $102.5M
- Amount sold
- $102.5M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapEMOTIV55 shared keywordsEmotiv develops wearable EEG systems and software platforms that capture and analyze brain signals to support neuroscience research, brain-computer interfaces, and cognitive AI applications. The platform serves researchers, developers, and organizations seeking to understand brain function and enable human-computer interaction.
Stratusneuro54 shared keywordsStratus Neuro provides EEG hardware products and clinical software solutions for hospital systems and neurology practices. The company distributes electroencephalography equipment including mobile cart systems, point-of-care nets, and ambulatory EEG kits for inpatient and outpatient neurodiagnostics.
Zeto Inc45 shared keywordsZeto develops improved electroencephalography technology for diagnosing epilepsy and other neurological conditions. The company serves physicians and medical institutions seeking advanced EEG diagnostic tools.
Companies competing with Ceribell for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Ceribell do?
- Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems. It serves healthcare providers in the neurodiagnostics and medical device field.
- Who founded Ceribell?
- Ceribell was founded by Josef Parvizi, Xingjuan (Jane) Chao.
- Who are Ceribell's investors?
- Ceribell's investors include Longitude Capital, RA Capital, Red Tree Venture, ShangBay Capital LLC.
- How much funding has Ceribell raised?
- Ceribell has disclosed $102.5M raised across 1 round.
- Where is Ceribell headquartered?
- Ceribell is headquartered in Sunnyvale, US.



